Related Experiment Video
Updated: Jun 16, 2026

Measuring Constipation in a Drosophila Model of Parkinson's Disease
Published on: September 22, 2023
Specific gut microbiota alterations and metabolic deficits in Parkinson's disease: a controlled comparison with
Shuang Yang1, Chen Tian2, Ding Peng1
1Department of Gastroenterology, Xuanwu Hospital Capital Medical University, Beijing, China.
Objective:
To isolate Parkinson's disease (PD)-specific gut dysbiosis from motility-related changes, this study compared the fecal microbiota of PD patients with constipation (PDC, n=20) against a functional constipation (FC, n=15) control group.
Methods:
High-throughput 16S rRNA gene sequencing and functional prediction were performed on fecal samples. Diversity metrics and taxonomic compositions were analyzed to identify PD-specific signatures.
Results:
The PDC group exhibited significantly higher microbial richness than the FC group (P = 0.01). Despite structural similarities driven by the shared constipation phenotype (ANOSIM R = 0.084), PDC was distinguished by specific compositional shifts, including the enrichment of Paraprevotella, Akkermansia, unclassified Ruminococcaceae, and Campylobacter. Functionally, the PDC microbiome showed significant deficits in tyrosine and glutathione metabolism pathways (P<0.05), indicating compromised dopamine precursor synthesis and antioxidant defense.
Conclusion:
By controlling for colonic transit time, this study identified specific microbial alterations and metabolic deficits in PD independent of constipation. These findings support a "gut-first" etiology linked to specific pathobionts and barrier compromise.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Gut-Brain Axis
Alterations in Muscle Tone lll